Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAEStro: MLC1501 in Stroke
NCT05046106Phase 3Not yet recruiting
- Sponsor
- Moleac
- Start
- Jan 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of MLC1501 in ischemic stroke, sponsored by Moleac. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
MLC1501
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05046106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046106.